Sign In

Aurélie Jean

Computational Scientist & Entrepreneur / Board member / Editorial contributor

Aurélie Jean, Ph.D., is a prominent figure in computational sciences and entrepreneurship. She serves as the Founder and CEO of In Silico Veritas (ISV), a company focused on developing and implementing algorithmic, data, and computational strategies for corporations and governments worldwide.24

Background

  • Education: Dr. Jean holds a Ph.D. from the École nationale supérieure des Mines de Paris in Material Sciences and Engineering (2006-2009). She also completed postdoctoral training at Penn State University (2009-2011) and Massachusetts Institute of Technology (2011-2016), both in Computational BioMechanics.2

Career Highlights

  • Senior Software Developer at Bloomberg LP: From April 2016 to November 2017, she worked as a Senior Financial Software Developer in New York City.2

  • Advisor at Boston Consulting Group: Between September 2018 and September 2020, she advised BCG on emerging technologies.2

  • Columnist for Les Echos: Since January 2021, she writes about science and technology news every two months on average.2

Involvements

Dr. Jean is also an investor in several companies including Aive (since May 2019), Cartoonbase (since January 2023), COLORI (since April 2022).2 Her work spans across various fields such as computational modeling, algorithmic governance, scientific due diligence on tech startups, evaluation of algorithmic biases, benchmarking technological analyses on products.45

However, there seems to be confusion with another company named Veritas In Silico Inc., which is based in Japan and focuses on mRNA-targeted drug discovery using proprietary in silico technology.13 This company does not appear to be related to Aurélie Jean or In Silico Veritas (ISV).

Highlights

Veritas In Silico Inc.
Jan 21 · scholar.google.com
Dr. Aurelie Jean, Ph.D.
ABOUT | Veritas In Silico Inc.
ABOUT | Veritas In Silico Inc.

Related Questions

What inspired Aurélie Jean to start In Silico Veritas?
How has Aurélie Jean's background in research influenced her leadership at ISV?
What are some of the key achievements of In Silico Veritas under Aurélie Jean's leadership?
How does ISV's approach to mRNA-targeted drug discovery differ from traditional methods?
What are the future plans and goals for In Silico Veritas?
Aurélie Jean
Aurélie Jean, photo 1
Aurélie Jean, photo 2
Add to my network

Location

United States